|
|
protein methylation
|
GO:0006479 |
81 |
0.433
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.294
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.249
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.236
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.195
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.184
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.168
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.150
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.145
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.138
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.131
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.128
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.127
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.124
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.120
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.118
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.114
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.114
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.091
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.088
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.086
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.084
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.080
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.079
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.074
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.072
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.069
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.065
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.064
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.063
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.060
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.060
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.059
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.057
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.056
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.056
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.053
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.051
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.051
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.048
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.048
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.045
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.045
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.040
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.039
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.039
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.039
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.039
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.038
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.038
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.037
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.037
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.036
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.034
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.033
|
|
|
|
translation
|
GO:0006412 |
93 |
0.032
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.031
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.031
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.031
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.031
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.031
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.030
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.030
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.029
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.029
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.028
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.028
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.028
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.027
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.027
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.026
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.026
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.025
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.025
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.025
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.025
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.024
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.024
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.024
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.024
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.024
|
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.023
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.023
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.023
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.023
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.023
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.023
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.023
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.022
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.022
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.022
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.022
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.022
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.022
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.021
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.021
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.021
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.021
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.021
|
|
|
|
memory
|
GO:0007613 |
58 |
0.021
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.020
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.020
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.020
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.020
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.020
|
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.020
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.019
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.019
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.019
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.019
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.019
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.019
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.019
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.019
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.019
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.018
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.018
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.018
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.018
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.017
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.017
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.017
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.017
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.017
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.017
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.017
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.016
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.016
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.016
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.016
|
|
|
|
regulation of dna templated transcription elongation
|
GO:0032784 |
10 |
0.016
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.016
|
|
|
|
regulation of response to drug
|
GO:2001023 |
2 |
0.016
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.016
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.015
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.015
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.015
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.015
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.015
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.015
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.015
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.015
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.015
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.015
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.014
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.014
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.014
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.014
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.014
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.014
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.014
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.014
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.014
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.014
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.013
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.013
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.013
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.013
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.013
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.013
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.013
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.013
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.013
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.013
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.013
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.013
|
|
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
22 |
0.013
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.013
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.013
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.013
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.013
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.013
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
|
|
|
regulation of synapse structural plasticity
|
GO:0051823 |
4 |
0.012
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.012
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.012
|
|
|
|
positive regulation of hormone metabolic process
|
GO:0032352 |
3 |
0.012
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.012
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.012
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.012
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.012
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.012
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
9 |
0.012
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.012
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.012
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.012
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.012
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.012
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.012
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.012
|
|
|
|
negative regulation of histone h3 k9 methylation
|
GO:0051573 |
4 |
0.012
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.012
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.012
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.012
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.012
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.012
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.011
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.011
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.011
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.011
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.011
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.011
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.011
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.011
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.011
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.011
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.011
|
|
|
|
leydig cell differentiation
|
GO:0033327 |
10 |
0.011
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.011
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.011
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.011
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.011
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.011
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.011
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.011
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.011
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.011
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.011
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.011
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.011
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.011
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.011
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.011
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.011
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.011
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.011
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.011
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.011
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.011
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.011
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.011
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.011
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.011
|
|
|
|
positive regulation of antimicrobial peptide production
|
GO:0002225 |
1 |
0.010
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.010
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.010
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.010
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.010
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.010
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.010
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.010
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.010
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.010
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.010
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.010
|
|
|
|
ubiquitin dependent protein catabolic process via the multivesicular body sorting pathway
|
GO:0043162 |
3 |
0.010
|
|